Peer Review History
| Original SubmissionFebruary 3, 2025 |
|---|
|
PCOMPBIOL-D-25-00221 Theory of axo-axonic inhibition PLOS Computational Biology Dear Dr. Brette, Thank you for submitting your manuscript to PLOS Computational Biology. After careful consideration, we feel that it has merit but does not fully meet PLOS Computational Biology's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 30 days May 18 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at ploscompbiol@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pcompbiol/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Hermann Cuntz Academic Editor PLOS Computational Biology Marieke van Vugt Section Editor PLOS Computational Biology Journal Requirements: 1) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019. 2) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: https://journals.plos.org/ploscompbiol/s/figures 3) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published. 1) State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)." Reviewers' comments: Reviewer's Responses to Questions Reviewer #1: This paper offers a tightly focused and important analysis examining the predictions of cable theory regarding GABAergic synaptic input on an axon initial segment. As described in the succinct but thorough introduction, the functional contributions of AIS input (particularly via chandelier cells) , the effect of such synapses have been surprisingly unclear despite the intuition that they afford powerful inhibition. This work grounds this intuition in a straight-forward, clearly written, and effective analysis, showing that this can occur via an effective increase in firing threshold that could strongly suppress the activity of target pyramidal cells under biologically feasible conditions. This fills a key gap in the literature, and provides useful baseline predictions for the effect of chandelier cells on neuronal networks, even if the unique biophysics of the AIS might complicate the real biology. Major Suggestions: * One of the most striking examples of inhibitory specificity is that chandelier cells _only_ target the axon initial segments. Given that somatic inhibition can also strongly suppress the activity of target pyramidal cells, it would be useful to thoroughly and quantitatively compare the effect of perisomatic inhibition with that of axonal inhibition. This contrast is briefly mentioned to in the text around line 139/140, but an explicit comparison would be valuable in trying to distinguish the roles of these two non-overlapping categories of inhibition, and this paper is well-suited to bring both categories of inhibitory targeting into the same analytical framework. * The biophysics of the AIS is complex (e.g. the very nice recent review by Jenkins and Bender, Axon Initial Segment Structure and Function in Health and Disease, 2025 Physiological Reviews), and there are structural hints that Chandelier cells react to this. In particular, chandelier synapses cluster onto cisternal organelles associated with ryanodine receptors suggesting some connection with calcium-dependent calcium release. There are also important differences in sodium and potassium channels compared to elsewhere on the neuronal surface. Notably, GABAergic input at the AIS seems focused on this biophysically distinct region and not just the initial span of AIS. The theory presented here is based in cable theory and offers a useful baseline model that has been generally lacking from the literature, but it would be useful to add some discussion of how AIS-specific biophysics might act on top of the phenomenon analyzed here. * There are some computational attempts to study AIS inhibition that are not discussed. Douglas and Martin 1990 (Control of Neuronal Output by Inhibition at the Axon Initial Segment) examined a similar geometry through simulation of Hodgkin-Huxley dynamics and came to a somewhat similar conclusion that AIS inhibition acts via controlling spike threshold. This study should be included in the otherwise excellent literature review in this paper, and it would be interesting to compare the results here with those found by Douglas and Martin. It would be instructive to compare the results here with those of this previous study, particularly as that study found it difficult for inhibition to overcome strong excitation, which is at least naively opposite to the estimates presented in the discussion (line 240–241). Similarly, Schneider-Mizell et al. 2021 included nonlinear biophysical simulations of inhibition at the AIS and compared to somatic inhibition, and could be included in this discussion. Minor points: * Line 96: A citation for the axial resistance of layer 5 pyramidal cells would be good. Reviewer #2: This is an excellent paper. Dr. Brette presents an analysis of the effect of GABAergic synaptic currents occurring at the axon initial segment, as occurs with axon-axonic synapses. The analysis is presented in a highly accessible manner that nicely communicates the concepts as well as the results to a general reader. The presentation nicely combines a simple conceptual view of voltage drops across the axon coupling the AIS to the soma with full simulations of neuronal firing. The paper is exceptionally well-written. It is concise and clear in both the presentation of results and in the discussion. I have only two suggestions for the author to consider. One is an explicit statement about how the effect of a given synaptic conductance at the AIS would differ from the same conductance on the soma. This is addressed indirectly in lines 185-194 in the context of analyzing synapses position along the AIS but a sentence explicitly comparing to a soma location might be useful. The second is a more complete consideration of the transient nature of the GABAergic currents. The analysis is of the steady-state situation but this is a simplification since the time-course of the synaptic conductance from a single firing of a presynaptic GABAergic is not long relative to the time course of capacitative charging. This point is alluded to in lines 236-240 but perhaps a more explicit statement would be helpful to the reader. I would leave both of these suggestions to be considered or rejected as the author feels is best. ********** Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 1 |
|
Dear Dr. Brette, We are pleased to inform you that your manuscript 'Theory of axo-axonic inhibition' has been provisionally accepted for publication in PLOS Computational Biology. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. Best regards, Hermann Cuntz Academic Editor PLOS Computational Biology Marieke van Vugt Section Editor PLOS Computational Biology *********************************************************** |
| Formally Accepted |
|
PCOMPBIOL-D-25-00221R1 Theory of axo-axonic inhibition Dear Dr Brette, I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! With kind regards, Anita Estes PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .